Anne L. Brunkan

679 citations
8 papers · 546 indexed · h-index 7
Topics
Alzheimer's disease research and treatments (7 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)Cellular transport and secretion (3 papers)

In The Last Decade

Anne L. Brunkan

8 papers receiving 533 citations

Peers

Anne L. Brunkan
Comparison fields: 5 of 52
  • Physiology 432
  • Molecular Biology 302
  • Pharmacology 165
  • Cellular and Molecular Neuroscience 94
  • Cell Biology 76
Replace Katja Fechteler with:
Katja Fechteler Germany
Daniela Kaden Germany
Manasi Benurwar United Kingdom
Inga Pinnix United States
Bernhard M. Kohli Switzerland
Sarah Veugelen United Kingdom
Joanna M. Cordy United Kingdom
Jody K. Lancia United States
Serena Salis Italy
Chris De Jonghe Belgium
Anne L. Brunkan relative to Katja Fechteler Germany Katja Fechteler's profile →
Citations per field
00.5×10×
Katja Fechteler · 1×
Citations per year

Countries citing papers authored by Anne L. Brunkan

Since Specialization
Citations

This map shows the geographic impact of Anne L. Brunkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne L. Brunkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne L. Brunkan more than expected).

Fields of papers citing papers by Anne L. Brunkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne L. Brunkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne L. Brunkan. The network helps show where Anne L. Brunkan may publish in the future.

Co-authorship network of co-authors of Anne L. Brunkan

This figure shows the co-authorship network connecting the top 25 collaborators of Anne L. Brunkan. A scholar is included among the top collaborators of Anne L. Brunkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne L. Brunkan. Anne L. Brunkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 27
2 111
3 5
4 22
5 57
6 132
7 166
8 26

About Anne L. Brunkan

Anne L. Brunkan is a scholar working on Physiology, Pharmacology and Cell Biology, having authored 8 papers that have together received 546 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Physiology (432 citations), Pharmacology (165 citations) and Aging (11 citations). Anne L. Brunkan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Alison Goate, Emily Walker, Maribel Martínez, Silva Hečimović, Jun Wang, Meera Saxena, Takeshi Iwatsubo, Michael S. Wolfe, Mark S. Shearman and Raphael Kopan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neurochemistry and Neurobiology of Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026